Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) and metabolic-associated fatty liver disease (MAFLD) are on the rise like any other liver disease, and tend to affect 25% of the United States population. The impact of NAFLD and MAFLD on patients with coronavirus disease 2019 (COVID-19) remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagirdhar, Gowthami Sai Kogilathota, Qasba, Rakhtan K, Pattnaik, Harsha, Rama, Kaanthi, Banga, Akshat, Reddy, Shiva Teja, Flumignan Bucharles, Anna Carolina, Kashyap, Rahul, Elmati, Praveen Reddy, Bansal, Vikas, Bains, Yatinder, DaCosta, Theodore, Surani, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292144/
https://www.ncbi.nlm.nih.gov/pubmed/37377589
http://dx.doi.org/10.3748/wjg.v29.i21.3362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292144/
https://www.ncbi.nlm.nih.gov/pubmed/37377589
http://dx.doi.org/10.3748/wjg.v29.i21.3362

Ejemplares similares